|
Fibrinolysis
Citations 11-20 of 32 total displayed.
|
Past content
(since Jun 1999):
|
- Editorial Commentaries
Blood Pressure Reduction and Tissue-Type Plasminogen Activator Release
- Nancy J. Brown
Hypertension 2006;47:648-649; published online before print as doi:10.1161/01.HYP.0000209952.30603.e9
[Full text]
- Original Articles
Impaired Capacity for Stimulated Fibrinolysis in Primary Hypertension Is Restored by Antihypertensive Therapy
- Wilhelm Ridderstråle, Erik Ulfhammer, Sverker Jern, and Thórdís Hrafnkelsdóttir
Hypertension 2006;47:686-691; published online before print as doi:10.1161/01.HYP.0000210540.35296.62
[Abstract]
[Full text]
- Scientific Contributions
Impaired Capacity for Stimulated Fibrinolysis in Primary Hypertension Is Restored by Antihypertensive Therapy
- Wilhelm Ridderstråle, Erik Ulfhammer, Sverker Jern, and Thórdís Hrafnkelsdóttir
Hypertension published March 6, 2006, doi:10.1161/01.HYP.0000210540.35296.62
[Abstract]
- Editorial Commentary
Blood Pressure Reduction and Tissue-Type Plasminogen Activator Release
- Nancy J. Brown
Hypertension published March 6, 2006, doi:10.1161/01.HYP.0000209952.30603.e9
[Abstract]
- Original Articles
Endogenous NO Regulates Plasminogen Activator Inhibitor-1 During Angiotensin-Converting Enzyme Inhibition
- Nancy J. Brown, James A.S. Muldowney, III, and Douglas E. Vaughan
Hypertension 2006;47:441-448; published online before print as doi:10.1161/01.HYP.0000202478.79587.1a
[Abstract]
[Full text]
- Scientific Contributions
Endogenous NO Regulates Plasminogen Activator Inhibitor-1 During Angiotensin-Converting Enzyme Inhibition
- Nancy J. Brown, James A.S. Muldowney III, and Douglas E. Vaughan
Hypertension published January 23, 2006, doi:10.1161/01.HYP.0000202478.79587.1a
[Abstract]
- Editorial Commentaries
Cardiovascular Benefits of Aldosterone Receptor Antagonists: What About Potassium?
- Gordon H. Williams
Hypertension 2005;46:265-266; published online before print as doi:10.1161/01.HYP.0000174329.99569.52
[Full text]
- Original Articles
Differing Effects of Mineralocorticoid Receptor–Dependent and –Independent Potassium-Sparing Diuretics on Fibrinolytic Balance
- Ji Ma, Francisco Albornoz, Chang Yu, Daniel W. Byrne, Douglas E. Vaughan, and Nancy J. Brown
Hypertension 2005;46:313-320; published online before print as doi:10.1161/01.HYP.0000174327.53863.86
[Abstract]
[Full text]
- Editorial Commentary
Cardiovascular Benefits of Aldosterone Receptor Antagonists. What About Potassium?
- Gordon H. Williams
Hypertension published July 18, 2005, doi:10.1161/01.HYP.0000174329.99569.52
[Abstract]
- Scientific Contributions
Differing Effects of Mineralocorticoid Receptor-Dependent and -Independent Potassium-Sparing Diuretics on Fibrinolytic Balance
- Ji Ma, Francisco Albornoz, Chang Yu, Daniel W. Byrne, Douglas E. Vaughan, and Nancy J. Brown
Hypertension published July 5, 2005, doi:10.1161/01.HYP.0000174327.53863.86
[Abstract]
|
|
